News
First patient enrolled in Modus’ sevuparin trial
Modus Therapeutics (Modus) – a company developing treatments for patients with high unmet medical needs – has announced the inclusion of the first patient in its SEVUSMART trial.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Modus Therapeutics (Modus) – a company developing treatments for patients with high unmet medical needs – has announced the inclusion of the first patient in its SEVUSMART trial.